Cargando…
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing
Pathogenic variants in BRCA1 and BRCA2 only explain the underlying genetic cause of about 10% of hereditary breast and ovarian cancer families. Because of cost‐effectiveness, multigene panel testing is often performed even if the clinical utility of testing most of the genes remains questionable. Th...
Ejemplares similares
-
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation
por: Ribeiro Guerra, Maximiliano, et al.
Publicado: (2021) -
Gene‐ and pathway‐level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility
por: Lonjou, Christine, et al.
Publicado: (2021) -
GENESIS: a French national resource to study the missing heritability of breast cancer
por: Sinilnikova, Olga M., et al.
Publicado: (2016) -
Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers
por: Renault, Anne-Laure, et al.
Publicado: (2018) -
Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families
por: Renault, Anne-Laure, et al.
Publicado: (2017)